Skip to main content
Skip to footer
Home
News Channels
All News
Reports
Press Room
Contact Us
About Us
All Categories
Antibodies
DNA RNA and Cells
More News
Proteins and Peptides
Small Molecules
Vaccines
Any Word
All Words
Exact Phrase
Biosimilar Antibodies & Proteins
Jun 2023
Ranibizumab (Lucentis) Biosimilars Pipeline Review
300,00€
Jun 2023
Aflibercept (Eylea) Biosimilars Pipeline Review
300,00€
Jun 2023
Ustekinumab (Stelara) Biosimilars Pipeline Review
300,00€
Mar 2023
2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics
120,00€
Feb 2023
Antibody Target, Technology & Pipeline Database: 1-Year Subscription
1.600,00€
Mar 2022
2021 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics
100,00€
←
1
2
Any Word
All Words
Exact Phrase
Report categories
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells
Drug the Undruggable Technologies
Immuno-Oncology
mRNA Vaccines & Therapeutics
NK Cells & CAR Macrophages
Pipeline Database
RNA-Targeted Therapeutics
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Antibodies
Therapeutic Proteins & Peptides
